Loading...
CIPLA AUSTRALIA PTY LTD, — Salmeterol Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #6 buyer for Salmeterol · $1.1M import value · 26 shipments · AUSTRALIA · DGFT Verified
CIPLA AUSTRALIA PTY LTD, is the #6 importer of Salmeterol from India with $1.1M in import value and 26 verified shipments. CIPLA AUSTRALIA PTY LTD, holds a 1.3% market share in Salmeterol imports based in AUSTRALIA. The company sources from 1 verified supplier across 12 formulations shipped to 1 country. Overall, CIPLA AUSTRALIA PTY LTD, imports 3 pharmaceutical products worth $2.9M across 2 therapeutic categories.
Verified from 26 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| CIPLA LIMITED | $1.1M | 26 | 100.0% |
CIPLA AUSTRALIA PTY LTD, sources Salmeterol from 1 verified Indian supplier based on 26 customs records. The primary supplier is CIPLA LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #6 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 14 | SEVEN PHARMA CHILE SPA | CHILE | $1.3M | 41 | $32.7K |
| 11 | SALUTAS PHARMA GMBH | GERMANY | $1.1M | 23 | $50.0K |
| 6 | CIPLA AUSTRALIA PTY LTD, ★ | AUSTRALIA | $950.0K | 19 | $50.0K |
| 16 | CONSIGNMENT STOCK OF S&D PHARMA CZ | NETHERLANDS | $849.1K | 27 | $31.4K |
| 17 | PT DANKOS FARMA | INDONESIA | $650.0K | 13 | $50.0K |
CIPLA AUSTRALIA PTY LTD, ranks #6 among 370 Salmeterol importers from India. Average shipment value of $50.0K compared to the market average of $61.5K. The closest competitors by value are SEVEN PHARMA CHILE SPA and SALUTAS PHARMA GMBH.
Destination countries from 26 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $1.1M | 26 | 100.0% |
CIPLA AUSTRALIA PTY LTD, imports Salmeterol to 1 country. The primary destination is AUSTRALIA receiving 100.0% of shipments worth $1.1M.
| Formulation | Value | Shipments |
|---|---|---|
| FLUTICASONE + SALMETEROL CIPLA 250/25 HF | $400.0K | 8 |
| FLUTICASONE SALMETEROL CIPHALER 250/50 M | $150.0K | 3 |
| FLUTICASONE + SALMETEROL CIPLA 250/25 HFA INHALER (FLUTICASONE PROPIONATE 250MCG + SALMETEROL XINAFOATE 25MCG | $104.4K | 3 |
| FLUTICASONE + SALMETEROL CIPLA 250/25 HFA INHALER (SALMETEROL XINAFOATE 25 MCG+FLUTICASONE PROPIONATE 250MCG INHALER) | $100.0K | 2 |
| FLUTICASONE SALMETEROL CIPHALER 500/50 | $80.1K | 3 |
| FLUTICASONE SALMETEROL CIPHALER 250/50 MCG/DOSE SALMETEROL 50 MCG AND FLUTICASONE DOCUMENT QTY 9240 PACK 1X60S = 554 | $50.0K | 1 |
| FLUTICASONE SALMETEROL CIPHALER 250/50 MCG/DOSE (SALMETEROL 50 MCG AND FLUTICASONE PROPIONATE 250MCG)(INV.QTY.8760 PACK | $50.0K | 1 |
| FLUTICASONE SALMETEROL CIPHALER 250/50 MCG/DOSE (SALMETEROL 50 MCG AND FLUTICASONE PROPIONATE 250MCG)(INV.QTY.8625 PACK |
What CIPLA AUSTRALIA PTY LTD, and other importers must comply with to import Salmeterol from India
Therapeutic Goods Administration (TGA)
Application for registration on the Australian Register of Therapeutic Goods (ARTG). Generic pathway requires bioequivalence and quality data per TGA guidelines.
Typical timeline: 10–14 months
TGA GMP clearance; PIC/S-aligned inspection of overseas manufacturing facilities
India exported $22.8M worth of Salmeterol through 7,006 shipments from 148 suppliers to 90 countries, serving 370 buyers globally. CIPLA AUSTRALIA PTY LTD, imports $1.1M of this total, accounting for 1.3% of India's Salmeterol exports with 26 shipments from AUSTRALIA. This is verified from 26 customs shipment records covering 12 distinct formulations.
CIPLA AUSTRALIA PTY LTD,'s average Salmeterol order value is $42.0K per consignment, based on 26 shipments totaling $1.1M. CIPLA AUSTRALIA PTY LTD, is based in AUSTRALIA and ranks #6 among all Salmeterol importers from India by value. The company sources from 1 verified supplier in India.
CIPLA AUSTRALIA PTY LTD, sources Salmeterol from 1 verified Indian supplier: CIPLA LIMITED ($1.1M, 100.0%). This is based on 26 customs records.
CIPLA AUSTRALIA PTY LTD, ranks #6 among 370 Salmeterol importers from India with a 1.3% market share. The top 3 importers are CIPLA MAROC ($4.4M), PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR ($3.3M), BREATHEFREE LANKA PVT LTD ($2.1M). CIPLA AUSTRALIA PTY LTD, processed 26 shipments from AUSTRALIA.
CIPLA AUSTRALIA PTY LTD, also imports these respiratory products. Each links to the detailed product page.
CIPLA AUSTRALIA PTY LTD, imports 3 products worth $2.9M. Beyond Salmeterol, top products include Fluticasone, Lenalidomide. View the complete CIPLA AUSTRALIA PTY LTD, profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Salmeterol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for CIPLA AUSTRALIA PTY LTD,'s Salmeterol imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
CIPLA AUSTRALIA PTY LTD,
Full Company Profile →
3 products · $2.9M total trade · 2 categories
| $50.0K |
| 1 |
| FLUTICASONE SALMETEROL CIPHALER 250/50 MCG/DOSE (SALMETEROL 50 MCG AND FLUTICASONE PROPIONATE 250 MCG)(INV.QT | $46.9K | 1 |
| FLUTICASONE + SALMETEROL CIPLA 250/25 HFA INHALER (SALMETEROL XINAFOATE 25 MCG+FLUTICASONE PROPIONATE 250MCG INHALER)NOS | $31.9K | 1 |
CIPLA AUSTRALIA PTY LTD, imports 12 distinct Salmeterol formulations from India. The top formulation is FLUTICASONE + SALMETEROL CIPLA 250/25 HF with 8 shipments worth $400.0K.
TGA manufacturing licence or sponsor licence for import; GMP clearance for each manufacturing site
Australian-specific labeling per TGO 91/92; English language; AUST R number
Note: TGA participates in PIC/S mutual recognition — PIC/S GMP certificate from India may expedite clearance.
Regulatory information is provided for general reference based on publicly available TGA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with TGA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 90+ countries, 370+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for CIPLA AUSTRALIA PTY LTD,.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Salmeterol. For current order-level data, contact TransData Nexus.